Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)

NCT03767322 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

558

Enrollment

OTHER

Sponsor class

Conditions

Contrast-induced Nephropathy
Contrast-induced Acute Kidney Injury

Interventions

DRUG: Allopurinol
DRUG: Febuxostat
DRUG: Placebo

Sponsor

Instituto Nacional de Cardiologia Ignacio Chavez

Collaborators

[object Object]
[object Object]